• Edit
DateInvestorsAmountRound
N/A

$1.0m

Early VC
*

N/A

Acquisition
Total Funding€951k

Recent News about Diopsys

Edit
More about Diopsysinfo icon
Edit

Diopsys specializes in visual electrophysiology, providing advanced diagnostic tools for ophthalmic practices. The company focuses on Visual Evoked Potential (VEP) and Electroretinography (ERG) tests, which are designed to be fast, easy, and non-invasive. These tests offer objective insights into the function of a patient's vision, making them invaluable for eye care professionals. Diopsys serves pediatric and adult eye care centers, helping doctors diagnose and monitor various vision disorders. The company's business model revolves around selling these diagnostic machines and providing ongoing customer support. Revenue is generated through the sale of equipment and potentially through service contracts for maintenance and updates. Diopsys operates in the medical device market, specifically targeting ophthalmology practices. The company is known for its superior customer service and its commitment to advancing the field of visual electrophysiology.

Keywords: visual electrophysiology, ophthalmic practices, VEP tests, ERG tests, non-invasive diagnostics, eye care, retina function, vision disorders, pediatric ophthalmology, medical devices.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.